Clinical Translational Sciences
Christof von Kalle
Our research focuses on genetics, gene therapy, immunology and cancer.
Our research focuses on genetics, gene therapy, immunology and cancer.
Hematopoiesis describes the process of blood formation and is sustained by the activity of hematopoietic stem and progenitor cells throughout our lifetime. While our understanding of stem cell biology continues to grow, it still remains challenging to study the in vivo activity of individual stem cells in humans.
We sequence cells to understand how genetic mutations form and change cell states in health and disease.
Rapid advances in molecular biology technologies are leading to a data explosion in biomedical research and clinical diagnostics. The goal of our department is to develop new and targeted ways to analyze and evaluate these data sets in order to implement innovations that benefit patients. For instance, it is desirable to make information from…
Since 2017, Martin Kircher heads the "Computational Genome Biology" working group at BIH. With the appointment as professor for regulatory genomics at the University of Lübeck and the University Hospital Schleswig-Holstein in 2022, Prof. Kircher continued his research as a BIH Fellow at the two locations. At the Berlin site, the research group is…
Our research focuses on molecular changes in the development of various tumors. We now want to use bioinformatic and experimental methods to better understand the early development of cancer in order to be able to intervene and prevent it in the long term.
The Haas group develops and applies novel multimodal single-cell and spatially-resolved technologies to study the complex etiology of hematological cancers and their interaction with the immune system.
The main research area of the Bioinformatics and Translational Genetics group is the elucidation of single gene disorders (diseases caused by DNA mutations in a single gene). We are developing user-friendly software that can be used by non-IT specialists. This allows the physicians – who know most about the patients and their disorders – to analyse…
Hypertension affects more than one billion people worldwide. As the leading risk factor for global disease burden, it contributes to more than nine million deaths annually. The mission of the Scholl group is the discovery and characterization of novel mechanisms underlying human disease. We focus on genetic causes of childhood hypertension and…